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Abstract  
Background Although subthreshold conditions are associated with impairment in numerous disorders, research 
on obsessive-compulsive disorder (OCD) below the diagnostic threshold of DSM-IV in the general population is 
limited. 
Purpose Estimate the DSM-IV 12-month prevalence, comorbidity and impairment of OCD, subthreshold OCD 
(i.e., fulfilling some but not all core DSM-IV criteria), and obsessive-compulsive symptoms (OCS) (i.e., 
endorsement of OCS without fulfilling any core DSM-IV criteria) in a general population sample.  
Methods Data from the German National Health Interview and Examination Survey - Mental Health Supplement 
(N = 4181, age 18-65 years), based on the standardized diagnostic interview Munich Composite International 
Diagnostic Interview. 
Results The 12-month prevalence of OCD was 0.7%, subthreshold OCD was 4.5%, and OCS was 8.3%. Subjects 
in all three groups showed higher comorbidity (odds ratios [ORs] 
€ 
≥  3.3), compared to those without OCS.  
OCD, subthreshold OCD and OCS were all associated with increased odds of substance abuse/dependence-, 
mood-, anxiety- and somatoform disorders, with especially strong associations with possible psychotic disorder 
(ORs 
€ 
≥  4.1) and bipolar disorders (ORs 
€ 
≥  4.7). Participants in all three groups showed higher impairment (ORs 
€ 
≥  3.1) and health-care utilization (ORs 
€ 
≥  2.4), compared to those without OCS, even after controlling for 
covariates.  
Conclusions Individuals with subthreshold OCD and OCS, not currently captured by DSM-IV OCD criteria, 
nevertheless show substantial comorbidity, impairment and health-care utilization. This should be taken into 
account in future conceptualization and classification of OCD and clinical care. 
 
Key words  
obsessive-compulsive disorder – obsessive-compulsive symptoms - epidemiology - mental disorder - cross-
sectional survey 
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Introduction 
Obsessive-compulsive disorder (OCD) is one of the ten most debilitating conditions among all physical 
and mental diseases worldwide [36]. According to the Diagnostic and Statistical Manual of Mental Disorders, 
Fourth Edition (DSM-IV) [1] the core clinical features of OCD are obsessions and/or compulsions. Obsessions 
are persistent thoughts, impulses, or images that are experienced as intrusive and inappropriate and cause anxiety 
or distress. Compulsions include repetitive behaviors or mental acts performed in response to obsessions and that 
are aimed at preventing or reducing the distress or some dreaded outcome. Those afflicted with OCD often have 
difficulty suppressing such thoughts or behaviors, although they usually recognize that the obsessions or 
compulsions are unreasonable and excessive [1].  
Recent epidemiological and clinical population studies suggest that subthreshold mental disorders, 
which by definition do not fulfill all of the required criteria of a given diagnosis, are common [25, 32, 33, 47]. 
These subthreshold mental conditions are not benign or simply diagnostic artifacts. Instead, individuals who 
endorse subthreshold conditions are likely to suffer from substantial comorbidity and impairment [32, 47]. 
Despite mounting evidence of the pernicious effects of subclinical conditions in general, the understanding of 
such issues in OCD is limited [2]. To date, only three studies (see Table 1) have examined impairment and 
health care utilization in relation to subthreshold conditions of OCD, defined as fulfilling at least one but not all 
core DSM-III-R/IV criteria [9, 22] or defined as the presence of obsessive-compulsive symptoms (OCS) 
according to DSM-IV as well as moderate distress [2]. These studies have found that the 12-month prevalence of 
subthreshold OCD was more frequent (0.6%-4.9%) [3, 9, 21, 51] than that of threshold OCD (0.3%-3.0%) [2, 7, 
9, 22, 29, 35, 48, 51, 55] in the general population and that the subthreshold conditions are strongly associated 
with more comorbidity, poorer functioning at work or in social activities and a greater use of health-care services 
[2, 3, 9, 21, 22].   
< Please insert Table 1 around here> 
It remains an open question whether these negative effects are associated with the presence of any 
subthreshold OCS or if a certain critical level of symptomatology must be achieved before the negative affects 
occur. Extant studies have documented that the phenomenon of OCS without further sub-clinical features does 
indeed exist and with substantial prevalence rates in the general population. Nestadt and colleagues [38] 
estimated the 1-month prevalence rate of OCS at 1.5% in the Eastern Baltimore Mental Health Survey sample. 
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This rather low rate may be based on the fact that the questions on OCS in the diagnostic interview applied in 
this study covered only three potential obsessions and compulsions, and, moreover, the features were only 
counted as OCS if they did ‘occur against conscious resistance’. In contrast, the 1-month prevalence of 
obsessions or compulsions in Canadian community sample was 26.2% and 22.2%, respectively [51]. In the 
Zurich study [14], 29.8% of young adult subjects endorsed OCS at least once during the longitudinal study 
period of 10 years. Likewise, the lifetime prevalence of OCS was 28.2% in the National Comorbidity Survey 
Replication (NCSR) sample [48]. The clinical importance of OCS without further sub-clinical features (i.e. none 
of the core DSM-III-R/IV criteria is fullfilled) remains largely unknown despite documentation of such 
substantial prevalence rates. Two studies by Fullana and colleagues [19, 20] reported that the presence of OCS 
dimensions (i.e., contamination; symmetry/ordering; harm/checking etc.) was associated with an increased risk 
of most mental disorders other than OCD. Nevertheless, to our knowledge, no epidemiological study has 
examined the differences in sociodemographic risk indicators, comorbidity and impairment across the various 
degrees of symptomatology (i.e., full-blown OCD, subthreshold OCD and OCS) using DSM-IV criteria for OCD 
in a general population sample in the same study.  
In the current paper, we address these open issues by using data from the German Health Interview and 
Examination Survey and its Mental Health Supplement. The purposes of this study are to determine the 12-
month prevalence of DSM-IV-defined OCD, subthreshold OCD (i.e., fulfilling at least one but not all core DSM-
IV criteria) and OCS (i.e., endorsement of at least one obsessive or compulsive symptom without fulfilling any 
of the core DSM-IV criteria) and examine how these varying levels are associated with sociodemographic 
characteristics, comorbid other mental disorders, current impairment, and health-care utilization in the general 
population.  
 
Material and methods 
Design and sample 
Data were taken from the German Health Interview and Examination Survey, Mental Health Supplement (GHS-
MHS))). The GHS-MHS assessed a subsample of the German Health Survey (GHS), the first nationwide cross-
sectional study in Germany for medical and social assessments, commissioned by the German Ministry of 
Science, Research and Education and the Robert Koch Institute and authorized by the relevant institutional 
review board and ethics committee. The GHS (core study) was designed to collect data on somatic disorders, 
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mental disorders, impairments, healthcare utilization and sociodemographic characteristics in a representative 
sample of 7124 subjects aged 18-79 living in Germany in 1997 (response rate: 61.4%). The sample was drawn 
from population registries from 113 communities throughout Germany with 130 sampling sites. For financial 
and logistical reasons the data for mental disorders were gathered using a two-stage design. The first stage 
entailed the administration of a 12-iem screening questionnaire for mental disorders (CID-S) [58] at the end of 
the medical examination of the core study (GHS). The second stage involved the separate administration of the 
computer-assisted version of the Munich Composite International Diagnostic Interview (DIA-X/M-CIDI)  to all 
core survey respondents who screened positive for a mental disorder and to a random sample of 50% who 
screened negative. This second stage forms the GHS-MHS and covered a subsample of the GHS (N = 4181; 
aged 18-65; conditional response rate: 87.6%). Due to the resulting oversampling of positive screenings , data 
were weighted in later analyses. Written informed consent was obtained for the GHS and the GHS-MHS. 
Detailed description of aims, design, and methods of the GHS have been described elsewhere [27]. 
  
Assessment 
The diagnostic assessments were based on the DIA-X/M-CIDI. The DIA-X/M-CIDI is a fully structured 
interview, a modified version of the World Health Organization CIDI (version 1.2; WHO, 1997), supplemented 
by questions to cover DSM-IV and ICD-10 criteria. The DIA-X/M-CIDI allows the assessment of symptoms, 
syndromes and diagnoses of mental disorders along with information about onset, duration, and 
clinical/psychological severity. The clinical interviewers were trained psychologists and physicians. Diagnostic 
findings reported in this paper were obtained by using the DIA-X/M-CIDI diagnostic algorithms [42]. All 
subsequent analyses were performed for 12-month criteria. The test-retest reliability of the full DIA-X/M-CIDI 
was good with kappa values ranging between 0.56 and 0.81 [59]. For the OCD, the test-retest reliability with an 
average time interval of 38 days between interviews, investigating in a general population sample of 60 subjects 
was found to be excellent (kappa = 0.81) [59]. The validity of the DIA-X/M-CIDI OCD diagnoses compared to 
diagnoses from independent treating physicians in a sample of 68 randomly chosen patients was also excellent 
(kappa = 0.91). The sensitivity was 100%, while the specificity was 98.4% [45].  
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Assessment of OCD 
The DIA-X/M-CIDI-OCD module contains two parts: one for the assessment of obsessions, and one for the 
assessment of compulsions. The obsession section begins with a stem question in order to scan a wide range of 
potential thoughts and cognitions presented in the form of a symptom list (“During the last 12 months, have you 
been bothered by having certain unpleasant thoughts or images like recurrent arbitrary thoughts, such as the idea 
that your hands are dirty or have germs on them?” [yes or no]). The rest of the obsession section is skipped 
entirely if the respondent answers no. If respondents acknowledge at least one item, they are subsequently asked 
for the mandatory DSM-IV criteria before providing information on the age of onset and last occurrence. In the 
subsequent section on compulsions, three stem questions are again presented to  assess whether he or she had 
engaged in repetitive behaviors (“doing something like washing hands over and over again” [yes or no] or 
“checking several times whether the door is locked” [yes or no]) or mental acts (“counting something like tiles in 
a floor” [yes or no]). This second part of the OCD section is also skipped when the respondent answers no. 
Respondents, who acknowledge at least one of these stem questions, are then asked for the remaining mandatory 
criteria A (diagnostic details of obsessions and compulsions), B (recognition that the obsessions or compulsions 
are excessive or unreasonable), and C (causes distress or dysfunction).  
 Based on the respondents’ responses from the DIA-X/M-CIDI-OCD section, this paper splits the 
sample into four mutually exclusive groups: 
(a) OCD: the subject met full DSM-IV criteria A, B, and C for OCD. 
(b) Subthreshold OCD: The subject affirmed at least one of the stem questions for obsessive or compulsive 
symptoms, and fulfilled at least one of the DSM-IV diagnostic criteria A, B or C, but not full DSM-IV 
criteria.  
(c) OCS: The subject affirmed at least one of the stem questions for obsessive or compulsive symptoms, 
but did not fulfill any of the DSM-IV criteria A, B or C. 
(d)  No OCS: the subject did not affirm any of the stem questions for obsessions or compulsions. 
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Sociodemographic correlates  
The following sociodemographic correlates of DSM-IV OCD, subthreshold OCD and OCS were examined: 
gender, age, marital status, working status, and social class. The assessment of social class was based on the 
Winkler-Index [57]. The Winkler-Index uses information about educational level, monthly net household 
income, and occupational position as indicators for social class. Each indicator ranges from 1 (the lowest status) 
to 7 (the highest status). The total index (Winkler-Index) values can therefore range between 3 and 21 points. 
Based on the total index values, three social classes were defined: 1) low (from 3 to 8 points), 2) middle (from 9 
to 14 points), and 3) high (15 to 21 points). 
 
Associations between OCD and other mental disorders 
The following DSM-IV mental disorders were used for comorbidity analyses: any mental disorder due to general 
medical conditions; substance use disorders (alcohol abuse/dependence, nicotine dependence, illicit substance 
abuse/dependence); possible psychotic disorder (In the DIA-X/M-CIDI, possible psychotic disorder included the 
experience of psychotic symptoms of delusions or hallucinations combined with speaking to a doctor about the 
symptoms); mood disorders (major depressive disorder, dysthymia, bipolar disorders); anxiety disorders (panic 
disorder with and without agoraphobia, agoraphobia without panic disorder, social phobia, simple phobias, 
phobic disorder not otherwise specified (NOS), generalized anxiety disorder); somatoform disorders 
(somatization disorder, undifferentiated somatoform disorder, somatic symptom index (SSI) 4/6, pain disorder, 
hypochondriasis); eating disorders (anorexia nervosa, atypical anorexia nervosa, bulimia nervosa, atypical 
bulimia nervosa, for definition see table 3). 
 
Impairment and health-care utilization 
Current impairment was assessed by asking the respondent whether he or she was completely or partially unable 
to carry out daily activities (function at work, in school or in family), because of psychological problems in the 
previous four weeks before the interview took place [yes or no]. Health-care utilization was evaluated by asking 
the respondent whether he or she had ever received at least a minimal intervention for any of his or her mental 
health conditions (i.e., “having ever sought any kind of treatment because of psychological problems or having 
been recommended by a doctor to seek any psychological or psychiatric treatment” [yes or no]).  
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Statistical analyses 
The data were weighted for age, gender, community distribution, and screening status in order to address 
different sampling probabilities and systematic non-response [27]. Statistical analyses were calculated using the 
STATA software package, version 10.0 [49], and the Huber-White sandwich matrix was applied for robust 
estimates of confidence intervals in case of weighted data [46]. Logistic regression (odds ratio [OR] with 95% 
confidence intervals [CI]) was used to examine associations between OCD, subthreshold OCD, OCS and 
covariates (sociodemographic characteristics, comorbid mental disorders, impairment, and health-care 
utilization). Throughout the paper, a p-value < 0.05 was considered as statistically significant. All comparisons 
were controlled for age and gender. 
 
Results 
12-month prevalence of OCD, subthreshold OCD and OCS 
The 12-month prevalence rate for OCD was 0.7% (95%CI = 0.4-1.1; weighted number [Nw] = 30), for 
subthreshold OCD 4.5% (95%CI = 3.8-5.2; Nw = 188), and for OCS 8.3% (95%CI = 7.4-9.2; Nw = 346). Thus, 
in the total sample 13.5% (95%CI = 12.3-14.7%; Nw = 564) of the 4181 subjects reported having experienced at 
least one OC symptom in the past 12 months. In the total sample, 86.5% (95%CI = 83.7-89.4; Nw = 3617) of the 
respondents reported no OCS during the last 12-months. 
 
Sociodemographic correlates  
No associations were found between OCD and gender-, age-, marital-, employment status, and social class 
(Table 2). The 12-month prevalence rates of subthreshold OCD and OCS were lower in the older age group (age 
50-65 years) compared to the younger age group (age 18-34 years) (subthreshold OCD: OR = 0.4, 95% CI = 0.3-
0.8; OCS: OR = 0.6, 95% CI = 0.4-0.9). The 12-month prevalence rates of OCS were higher in the separated, 
divorced, or widowed subjects group, when compared to those who were married (OR = 1.6, 95% CI = 1.1-2.4). 
No socio-demographic correlates were found for subthreshold OCD and OCS with gender, employment status 
and social class.  
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< Please insert Table 2 around here> 
 
12-month comorbidity with other mental disorders 
Higher rates of comorbidity were found for almost all of the assessed DSM-IV mental disorders in subjects with 
OCD, subthreshold OCD and OCS as compared to subjects with No OCS (see Table 3).  At least one mental 
disorder other than OCD was assessed in 89.2% of the subjects with OCD, 65.9% of the subjects with 
subthreshold OCD, and 61.2% of the subjects with OCS. OCD, subthreshold OCD and OCS were all associated 
with elevated odds for having at least one mental disorder other than OCD, when compared to the No OCS 
group. 
 Not only OCD, but also subthreshold OCD and OCS were associated with elevated odds for substance 
abuse/dependence-, mood-, anxiety disorders, and somatoform disorders/syndromes when compared to the No 
OCS group. In addition, OCD, subthreshold OCD and OCS were all associated with increased odds of the 
presence of possible psychotic disorder and bipolar disorder, compared to No OCS.  
< Please insert Table 3 around here> 
 
Impairment and health-care utilization  
The subjects in the OCD, subthreshold OCD and OCS groups showed increased rates of impairment (Table 4), 
with endorsements of 60.1%, 19.9%, and 21.1% respectively. OCD, subthreshold OCD and OCS were 
associated with elevated odds for impairment compared to the No OCS group. Importantly, OCD and OCS were 
associated with impairment even after adjusting for age, gender and mental disorders other than OCD. 
 Considerable rates of health-care utilization were also found in the OCD, subthreshold OCD and OCS 
groups, with endorsement of having ever used health-care because of mental problems in 68.2%, 36.3%, and 
36.6% respectively (see Table 4). OCD, subthreshold OCD and OCS were again associated with elevated odds 
for health-care utilization compared to No OCS. Finally, the association between health-care utilization and 
OCS, but not OCD or subthreshold OCD, remained significant when adjusting for gender, age and mental 
disorders other than OCD. 
< Please insert Table 4 around here> 
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Discussion 
Using data from a representative population sample that was assessed with a well-established standardized 
diagnostic interview, we examined the 12-month prevalence of OCD, subthreshold OCD and OCS and their 
associations with sociodemographic characteristics, comorbid other mental disorders, current impairment, and 
health-care utilization. Unlike previous research, we divided the subthreshold groups into two groups that varied 
by severity (i.e., endorsing at least one symptom of obsessions or compulsions vs. endorsing at least one 
symptom plus one of the core DSM-IV criteria). By demonstrating the impact of OCS, our results added 
important evidence to previous research on subthreshold OCD. It has been argued that OCD should be defined 
using less restrictive criteria because subthreshold OCD might better describe the clinical reality of individuals 
who suffer from this symptomatology [22, 50]. Our findings suggest that OCS without further sub-clinical 
features is indeed clinically meaningful, both in its own right and in the extremely common presentation with 
comorbid conditions. 
 The 12-month prevalence of OCD found in this study (0.7%) correspondents to previous studies 
conducted on the general population, with ranges from 0.3-3.0% [2, 7, 9, 22, 29, 35, 48, 51, 55]. Twelve-month 
prevalence rates of 0.6% to 4.9% for subthreshold OCD that fulfill some but not all the required DSM-IV criteria 
of threshold OCD (4.5%) is likewise consistent with previous studies [3, 9, 21, 51]. In our effort to further 
scrutinize subthreshold OC conditions, we examined OCS without further OCD features and found a 12-month 
prevalence of 8.3%. It is important to highlight that our OCS definition differed from previous research on 
subthreshold OCS, as these studies required the endorsement of further (sub) threshold OCD features.  
The overall 12-month prevalence of individuals who report experiencing at least one OC symptom was 
13.5% in this representative sample. This is in accordance with the OCS dimensions study by Fullana and 
colleagues [20] (13%). However, our finding is considerably lower than the prevalence of OCS examined in 
Switzerland (lifetime 29.8%) [14], in the USA (lifetime 28.2%) [48], and in Canada (1-month 22.2-26.2%) [51], 
while it is higher than the finding from the study by Nestadt and colleagues [38] (1-month 1.5%) in the USA. 
Methodological differences across the studies likely account for these varying rates.  Previous studies have 
utilized different diagnostic criteria (i.e., DSM-III OCD criteria versus DSM-IV OCD), time frames, 
instruments, and sampling methods. According to Fontenelle and colleagues [18] the majority of socio-
demographic features and core phenomenological symptoms of OCD were relatively independent of geographic, 
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ethnic and cultural differences across samples from Brazil, North-, Latin America, Europe, Africa and Asia. 
Nevertheless, the interpretation of prevalence differences between countries is difficult [5] because of the 
paucity of studies that examine OCD across cultures  [18]. 
We did not find gender differences regarding the 12-month prevalence rates of OCD, subthreshold 
OCD, and OCS, which is supported by several studies [8, 9, 29], but contradictory to some reports of gender 
differences in the prevalence of subthreshold OCD [22] or OCS [14, 20].  
Consistent with the previous epidemiological and clinical studies that reported decreased prevalence 
rates of DSM-IV OCD in the elderly [8, 17, 35, 48, 55], our subjects in the older age group (age: 50-65 years) 
showed a lower prevalence rate of subthreshold OCD and OCS compared to the younger age group (age: 18-34 
years).  
 We were able to replicate previously reported strong associations between OCD and substance 
abuse/dependence- [9, 48], mood- [8, 10, 21, 29, 48, 55], anxiety- [2, 8, 9, 21, 29, 48, 55] and somatoform 
disorders [21]. In addition, we also found strong associations between subthreshold OCD and these same 
disorders consistent with previous research [2, 3, 9, 21]. Unlike most studies, however, we additionally 
examined the association between OCS and these disorders. Results suggest that the mere presence of OCS is 
associated with increased odds for having substance-, mood-, anxiety-, and somatoform disorders in the subjects 
with OCS compared to subjects with No OCS.  
Consistent with clinical studies that have documented frequent comorbidity between OCD and bipolar 
disorders [24, 31, 34, 40, 41], this sample revealed strong associations between bipolar disorders and OCD, 
subthreshold OCD and OCS (ORs 
€ 
≥  4.7). The association between bipolar disorders and the varying definitions 
of OCD was stronger than the association between the OCD definitions and major depression. This is compatible 
with previous reports that found a higher co-occurrence of OCD and bipolar disorders than OCD and major 
depression in the ECA study [6] and in the Zurich study [3].  
Of special interest is our finding of the strong association between possible psychotic disorder with 
OCD, subthreshold OCD and OCS groups (ORs 
€ 
≥ 4.1). Our finding showed that 39.3% of the subjects with 
OCD, 6.5% of the subjects with subthreshold OCD, and 7.3% of the subjects with OCS met diagnostic criteria of 
possible psychotic disorder. The frequent co-occurrence of OCD and psychotic disorders are well documented in 
epidemiological and clinical studies [4, 9, 15, 16, 26, 37, 39, 43, 44, 53] and possible pathophysiological 
overlapping between OCD and psychotic disorders has been suggested [23, 54]. Nevertheless, in a study by de 
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Haan and colleagues [12] psychotic disorders were present in only 1.7% of patients with OCD, and De Haan and 
colleagues [13] suggested that treatment of psychosis induces OCS or OCD in some patients with a primary 
diagnosis of psychosis. Indeed, using a prospective longitudinal design, de Haan and colleagues [11] found that 
severity of OCS was associated with duration of antipsychotic treatment using olanzapine in hospitalized young 
patients with psychosis. There is also a case report in which OCS arose during the use of antipsychotic in a non-
psychotic, bipolar patient [28]. On the other hand, van Nimwegen and colleagues [56] demonstrated a significant 
and clinically relevant decrease in the presence of OCS with antipsychotic treatment in a six-week, randomized 
and double-blind multi-center study in young in- and outpatients with psychosis. De Haan and colleagues [11] 
suggested that genetic variation in patients with schizophrenia might be related to increase or decrease in OCS 
during antipsychotic treatment. Future epidemiological and clinical study should scrutinize the relationship of 
these disorders in more detail.  
 Finally, our findings are consistent with previous studies that found strong impairment and frequent use 
of health-care in subjects with OCD [3, 22, 30, 48, 52, 55] and in subjects with subthreshold OCD [2, 9, 22]. 
Moreover, we additionally found that the presence of OCS alone has considerable impact on impairment and 
health-care utilization. Importantly, the associations between OCS and impairment and health-care utilization 
remained significant, even after adjusting for comorbid mental disorders.  
 The findings of this paper should be interpreted in light of several limitations. First, although the GHS-
MHS examined a wide range of mental disorders, several disorders that are supposed to be related to OCD were 
not included, such as several OC spectrum disorders (e.g. body dysmorphic disorder, pathologic grooming 
habits, and impulse control disorders). Second, the GHS-MHS data are based on the respondents’ self-reports 
and are based on their recollections, recall bias could have influenced in some cases the accuracy of information 
regarding the determination of onset in the analyses of clinical significance (e.g. impairment, health-care 
utilization). Third, health-care use was measured for lifetime, while diagnoses covered the previous 12 months. 
Fourth, as the number of subjects with DSM-IV OCD was small (N = 38), some cells in the analyses of 
comorbidity were very small.   
In spite of these limitations, our findings suggest that subjects not only with subthreshold OCD but also 
with OCS only, both not currently captured by DSM-IV OCD criteria, nevertheless show substantial 
comorbidity, impairment and health-care utilization. This should be taken into account in future 
conceptualization and classification of OCD (DSM-V and ICD-11). Moreover, this may have implications for 
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clinical practice, in the way that also subjects with OCS only may require attention. Finally, future studies that 
focus on subjects with OCS only are highly warranted to increase our understanding of this condition. 
Taken together, the strong associations obtained in our study between the presence of subthreshold 
OCD, OCS and comorbidity, impairment, or health-care utilization suggest that the presence of the full spectrum 
from OCS through full diagnostic OCD has important implications for the diagnosis, intervention, and quality of 
life of those affected.   
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Table 1: Previous epidemiological studies estimating impairment and health care use in subjects with 
subthreshold OCD  
Study  Sample  Instrument Interviewer Prevalence rates Definition of 
subthreshold OCD 
Transitions in 
Alcohol 
Consumption 
and Smoking 
Grabe et al. 
(2000)  
4075 
(Age 18-64) 
DSM-IV; 
DIA-X/ 
M-CIDI  
Lay Lifetime: 
OCD 0.5% 
Subthreshold 
OCD 2% 
 
12-Month: 
OCD 0.39% 
Subthreshold 
OCD 1.6% 
The presence of OC 
symptoms of DSM-IV a 
+ at least one criterion 
of the DSM-IV criteria 
A, B, C for OCD is 
affirmed b 
The Zurich 
Study 
Angst et al. 
(2004) 
591 
(Age 20-40) 
 
DSM-IV; 
SPIKE  
Psychiatrist/ 
Clinical 
psychologist 
Lifetime: 
OCD 3.5% 
Subthreshold 
OCD 8.7% 
The presence of OC 
symptoms of DSM-IV a 
+ moderate distress 
(29-49 on the analogue 
scale 0-100) 
The Netherlands 
Mental Health 
Survey and 
Incidence Study 
(NEMESIS) 
de Bruijn et al. 
(2010) 
7076 
(Age 18-64) 
DSM-III-
R; 
CIDI  
Lay Lifetime: 
OCD 0.9% 
Subthreshold 
OCD 4.9% 
The presence of OC 
symptoms of DSM-III-
R a + at least criterion 
A is affirmed c 
 
Abbreviations: CIDI = The Composite International Diagnostic Interview; DIA-X/M-CIDI = The Munich Composite International 
Diagnostic Interview; DSM-III-R = Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised; DSM-IV = 
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition; OC = obsessive-compulsive; OCD = obsessive-compulsive 
disorder; SPIKE = The Structured Psychopathological Interview and Rating of the Social Consequences for Epidemiology. 
a For example, thoughts of violence, contamination, doubt, or behaviors such as washing, checking, ordering, and hoarding; b The DSM-
IV OCD criteria: criterion A (Obsessions: The symptoms are recognized as a product of the own mind, are recurrent and persistent and 
not simply excessive worries about real life problems; the person attempts to ignore, suppress or neutralize them. Compulsions: 
Repetitive behaviors or mental acts in response to an obsession or according to rules, which are aimed at preventing or reducing distress 
or dreaded events (even though this response is excessive or connected to the obsession in an unrealistic way), criterion B (The person 
recognizes the symptoms are excessive or unreasonable), criterion C (The symptoms are time consuming -at least one hour per a day- or 
cause a substantial impairment or distress); c The DSM-III-R OCD criterion A (The symptoms are repetitive or recurrent and the person 
recognizes the symptoms are excessive or unreasonable).  	
  
Table 2: Sociodemographic correlates of OCD, subthreshold OCD and OCS 
(12-month prevalences if correlate present [weighted data]) 
 
 OCD 
(n = 30) 
 
 Subthreshold OCD 
(n = 188) 
 OCS 
(n = 346) 
 % ORa 95% CI  % ORa 95% CI  % ORa 95% CI 
Gender            
Male 0.6 1.0   4.0 1.0   7.9 1.0  
Female 0.9 1.6 (0.7-3.3)  5.0 1.2 (0.9-1.8)  8.7 1.1 (0.8-1.5) 
Age            
18-34 years 0.7 1.0   5.7 1.0   9.7 1.0  
35-49 years 0.9 1.3 (0.5-2.9)  4.7 0.8 (0.5-1.2)  8.6 0.8 (0.6-1.2) 
50-65 years 0.5 0.7 (0.3-1.8)  2.9 0.4* (0.3-0.8)  6.3 0.6* (0.4-0.9) 
Marital status            
Married 0.5 1.0   3.9 1.0   7.6 1.0  
Single 0.9 1.7 (0.6-4.9)  6.5 1.4 (0.9-2.3)  8.5 0.8 (0.6-1.3) 
Separated/divorced
/ widowed 
1.4 2.5 (0.9-6.4)  4.1 1.0 (0.6-1.8)  11.7 1.6* (1.1-2.4) 
Employment status            
Fulltime 0.7 1.0   4.2 1.0   7.9 1.0  
15-34h/week 0.7 0.6 (0.1-3.2)  6.8 1.6 (0.9-3.0)  7.8 0.9 (0.6-1.7) 
<15h/week 0 - -  4.8 1.1 (0.5-2.6)  9.8 1.2 (0.6-2.5) 
Retired 0.6 0.6 (0.1-2.4)  3.3 1.0 (0.4-2.3)  5.9 0.9 (0.5-1.7) 
School/student 0.9 1.2 (0.3-4.4)  5.1 0.9 (0.5-2.0)  8.4 0.8 (0.5-1.5) 
Unemployed 1.1 1.2 (0.3-5.2)  3.1 0.7 (0.3-1.7)  9.5 1.2 (0.8-2.1) 
Homemaker 0.6 0.5 (0.1-2.1)  4.9 1.1 (0.6-2.2)  9.8 1.2 (0.8-2.0) 
Social class b            
Low 1.1 1.0   5.5 1.0   9.1 1.0  
Middle 0.7 0.6 (0.2-1.5)  4.4 0.7 (0.5-1.2)  8.1 0.8 (0.6-1.2) 
High 0.4 0.3 (0.1-1.2)  4.2 0.7 (0.4-1.3)  8.1 0.9 (0.6-1.4) 
Abbreviations: OCD = obsessive-compulsive disorder; OCS = obsessive-compulsive symptoms; OR = odds ratios from logistic 
regression and 95% confidence intervals (CI) adjusted for age and gender. *p < 0.05. 
a All three groups were compared with No OCS separately for logistic regression.  
b Based on ‘Index of social class’ (Winkler & Stolzenberg, 1998) derived from information on education, income and occupational 
position. Each indicator ranges from 1 (the lowest status) to 7 (the highest status). The total index values can take between 3 and 21 
points. Threes social classes were defined based on the total values: Low (from 3 to 8), Middle (from 9 to 14 points), and High (15 to 21 
points). 	
  
Table 3: 12-month prevalences of other DSM-IV disorders in OCD, subthreshold OCD and OCS (weighted data) 
 OCD 
(n = 30) 
 Subthreshold OCD 
(n = 188) 
 OCS 
(n = 346) 
 No OCS 
(n = 
3617) 
DSM-IV disorder % OR 95% CI  % OR 95% CI  % OR 95% CI  % 
Mental disorder due to general medical condition 6.1 5.5* h (1.1-25.8)  1.6 1.5 (0.5-4.6)  3.3 3.1* (1.6-6.2)  1.1 
Any substance abuse/dependence a 30.0 3.3* (1.5-7.3)  24.5 2.3* (1.5-3.5)  22.7 2.1* (1.6-2.9)  11.6 
     Alcohol abuse/dependence 14.1 6.3* (2.2-18.1)  11.3 4.1* (2.2-7.6)  9.8 3.5* (2.2-5.6)  3.1 
     Nicotine dependence 23.1 2.9* (1.2-6.8)  16.4 1.7* (1.1-2.8)  17.2 1.9* (1.4-2.7)  9.2 
     Any illicit substance abuse/dependence 1.9 2.7 h (0.3-21.0)  2.0 2.6 (0.7-8.9)  1.2 1.7 (0.6-4.9)  0.6 
Possible psychotic disorder b 39.3 39.8* (18.7-84.8)  6.5 4.1* (2.1-8.3)  7.3 4.7* (2.9-8.0)  1.6 
Any mood disorder c 69.0 21.3* (9.5-47.8)  29.6 4.0* (2.8-5.9)  23.8 3.0* (2.3-4.1)  9.4 
     Major depressive disorder 45.4 10.8* (5.2-22.2)  22.8 3.9* (2.6-5.9)  18.6 3.0* (2.2-4.3)  6.9 
     Dysthymic disorder 42.5 23.7* (11.2-50.2)  10.9 4.0* (2.3-7.0)  11.0 4.0* (2.7-6.0)  3.2 
     Any bipolar disorder 10.0 22.6* (6.3-80.9)  4.1 8.2* (3.4-19.7)  2.3 4.7* (2.0-11.2)  0.4 
Any anxiety disorder other than OCD d 66.8 16.4* (7.4-36.2)  39.0 5.2* (3.7-7.4)  29.5 3.4* (2.6-4.6)  11.0 
     Panic disorder with/without agoraphobia 23.7 18.5* (8.0-42.9)  4.3 2.7* (1.3-5.7)  7.4 5.0* (3.0-8.4)  1.6 
     Agoraphobia without panic disorder 8.4 6.5* (1.8-24.1)  7.0 6.0* (3.2-11.3)  6.1 5.2* (3.1-8.8)  1.3 
     Panic attack 33.9 14.2* (6.4-31.3)  11.1 3.5* (2.2-5.9)  12.4 4.1* (2.7-6.1)  3.4 
     Social phobia  32.7 32.1* (13.9-74.1)  4.4 2.9* (1.3-6.7)  4.1 2.8* (1.6-5.1)  1.4 
     Any simple phobia e 28.8 5.9* (2.8-12.5)  23.4 4.7* (3.1-7.1)  15.1 2.7* (1.9-4.0)  5.9 
     Phobic disorder NOS 11.5 4.1* (1.4-12.3)  9.5 3.6* (2.0-6.4)  5.6 2.0* (1.2-3.4)  2.8 
     Generalized anxiety disorder 21.1 25.9* (10.7-62.8)  4.1 4.3* (1.9-9.9)  3.1 3.2* (1.6-6.4)  1.1 
Any somatoform disorder/syndrome f 51.8 10.4* (4.8-22.7)  20.4 2.5* (1.7-3.8)  20.7 2.6* (1.9-3.6)  9.3 
     SSI 4/6 12.4 3.7* (1.3-10.7)  9.3 2.8* (1.6-5.1)  7.7 2.3* (1.5-3.6)  3.7 
     Pain disorder 47.2 11.9* (5.4-26.5)  13.1 2.0* (1.2-3.2)  15.2 2.4* (1.7-3.5)  6.9 
     Hypochondriasis 0 - -  0.4 22.8* h (1.4-348.7)  0.3 16.1* h (1.04-249.7)  0.02 
Any eating disorder g 1.7 6.2 h (0.7-48.5)  0.5 1.6 h (0.3-7.8)  1.2 4.3* (1.2-15.4)  0.2 
Any of above 89.2 16.8* (5.1-55.9)  65.9 3.9* (2.8-5.7)  61.2 3.3* (2.5-4.3)  32.1 
Abbreviations: CI = confidence intervals; DSM-IV = Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition; OCD = obsessive-compulsive disorder; OCS = obsessive-compulsive symptoms; OR = 
odds ratios from logistic regression adjusted for age and gender, ‘No OCS’ as a reference group. *p < 0.05. 
a With nicotine dependence; b In the DIA-X/M-CIDI, possible psychotic disorder included the experience of psychotic symptoms of delusions or hallucinations combined with speaking to a doctor about the 
symptoms; c Major depressive disorder, dysthymic disorder, bipolar I disorder, bipolar II disorder, single hypomanic episode; d Panic disorder with/without agoraphobia, agoraphobia without panic disorder, social 
phobia, any simple phobia, phobic disorder not otherwise specified (NOS), generalized anxiety disorder; e Animal, natural environment, blood-injection-injury, situational type; f Somatization disorder, 
undifferentiated somatization disorder, somatic symptom index SSI 4/6 (according to Escobar et al. (1989) four somatoform symptoms for males and six for females), pain disorder, hypochondriasis; g Anorexia 
nervosa, atypical anorexia nervosa (all DSM-IV criteria for anorexia are met except D or all are met except A, but BMI < 18.5) , bulimia nervosa, atypical bulimia nervosa (all DSM-IV criteria for Bulimia met, 
except C criteria or except B criteria ; h These associations are based on a small number of comorbid cases (≤ 2).  
	
  
Table 4: Impairment and health-care utilization in OCD, subthreshold OCD and OCS (weighted data) 
 OCD 
(n = 30) 
 Subthreshold OCD 
(n = 188) 
 OCS 
(n = 346) 
 No OCS 
(n = 3617) 
 % OR 95% CI  % OR 95% CI  % OR 95% CI  % 
Impairment a 60.1    19.9    21.1    7.2 
Adjusted for gender and age  19.0* (9.0-40.2)   3.1* (2.0-4.7)   3.4* (2.5-4.6)  OR = 1.0 
Adjusted for gender, age and comorbid 
disorders b 
 3.8* (1.1-12.6)   1.4 (0.9-2.3)   1.9* (1.3-2.8)  OR = 1.0 
              
Health-care utilization c 68.2    36.3    36.6    19.5 
Adjusted for gender and age  8.8* (4.0-19.5)   2.4* (1.7-3.4)   2.4* (1.9-3.2)  OR = 1.0 
Adjusted for gender, age and comorbid 
disorders b 
 2.1 (0.8-5.4)   1.3 (0.9-2.0)   1.5* (1.1-2.1)  OR = 1.0 
Abbreviations: CI = confidence intervals; OCD = obsessive-compulsive disorder; OCS = obsessive-compulsive symptoms; OR = odds ratios from logistic regression, ‘No OCS’ as a reference group; SD = standard 
deviation. *p < 0.05. 
a Based on the items of disability days (complete or partial) (yes/no). 
b Comorbid disorders include mental disorder due to general medical condition, any substance abuse/dependence, possible psychotic disorder, any mood disorder, any anxiety disorder other than OCD, any 
somatoform disorder/syndrome, any eating disorder. 
c Presented in form of a variable ‘at least minimal intervention’: a combination of questions for “Having ever been seeking any psychological or psychiatric treatment due to mental problems or been recommended by 
a doctor to do so” (yes/no) 
  
 	
  
